Accelerating Precision Medicine in Oncology Through Federated Learning - Top-Institutions - MDSpire

Accelerating Precision Medicine in Oncology Through Federated Learning

  • By

  • Jo Cavallo

  • February 24, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology
    • Cancer Genomics
    • Artificial Intelligence in Medicine

  • #2

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Oncology
    • Cancer Immunotherapy
    • Computational Biology

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology
    • Cancer Genomics
    • Machine Learning

  • #4

    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    Baltimore, MD

    Key Differentiators

    • Oncology
    • Biomedical Engineering
    • AI in Cancer Research

Original Source(s)

Accelerating Precision Medicine in Oncology Through Federated Learning

  • by Jo Cavallo

  • February 24, 2026

Related Content

Beyond Nodule Detection: AI, Chest CT, and a Vision for Population Health

Lung cancer resulted in 1.8 million deaths globally in 2022 and remains the leading cause of cancer-related mortality worldwide. Low-dose CT screening has been shown to reduce lung cancer mortality, a...

2026 NCCN Clinical Practice Guidelines in Oncology®: Key Updates Across Tumor Types

The National Comprehensive Cancer Network® (NCCN®) first introduced the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) in 1996, initially covering eight tumor types. Three decades la...

Preclinical Study in Mice Addresses a Question: Should RAS Inhibitors Be Given Preemptively?

With recent data that RAS inhibition can improve survival in metastatic pancreatic cancer, the optimization of these agents has become a research priority. Minh Than, MD, PhD, a clinical and research ...